| Gene Symbol | CACNA1A |
|---|
| Full Name | Calcium Voltage-Gated Channel Subunit Alpha1 A |
|---|
| Chromosomal Location | 19p13.13 |
|---|
| NCBI Gene ID | [774](https://www.ncbi.nlm.nih.gov/gene/774) |
|---|
| OMIM | [117013](https://www.omim.org/entry/117013) |
|---|
| Ensembl | [ENSG00000159289](https://www.ensembl.org/Homo_sapiens/Gene?g=ENSG00000159289) |
|---|
| UniProt | [Q00978](https://www.uniprot.org/uniprotkb/Q00978) |
|---|
| Protein Class | Voltage-gated calcium channel, P/Q-type (CaV2.1) |
|---|
| Expression | Cerebellum (Purkinje cells), brainstem, cerebral cortex |
|---|
SCA6 (Spinocerebellar Ataxia Type 6) is caused by CAG trinucleotide repeat expansions in the CACNA1A gene, which encodes the P/Q-type voltage-gated calcium channel (CaV2.1)[@zhuchenko1997]. This channel is essential for synaptic transmission, particularly in Purkinje cells of the cerebellum, where it mediates calcium influx necessary for neurotransmitter release and dendritic excitability.
The CACNA1A gene is one of the most neurologically important calcium channel genes, with mutations causing multiple allelic disorders including:
- Spinocerebellar Ataxia Type 6 (SCA6)
- Familial Hemiplegic Migraine Type 1 (FHM1)
- Episodic Ataxia Type 2 (EA2)
- Epileptic encephalopathy
This page covers the gene's normal function, disease mechanisms, expression patterns, and therapeutic approaches relevant to neurodegeneration[@pietrobon2010].
¶ Gene Structure and Normal Function
The CACNA1A gene is located on chromosome 19p13.13 and spans approximately 350 kb. It consists of 47 exons encoding the alpha-1A subunit of the P/Q-type calcium channel. The CAG repeat expansion responsible for SCA6 is located in the 3' coding region of the gene[@matsushita1999].
The CaV2.1 channel is a large transmembrane protein (~2500 amino acids) with:
- S1-S6 transmembrane segments in each of four homologous domains (I-IV)
- Voltage-sensing domain (S1-S4) that detects membrane depolarization
- P-loop region (S5-S6) forming the ion conduction pore
- C-terminal tail containing interaction domains for regulatory proteins
- Multiple splice variants creating functionally diverse channel isoforms
The P/Q-type calcium channel plays critical roles in cerebellar function:
Synaptic Transmission: CaV2.1 channels are essential for neurotransmitter release at parallel fiber-Purkinje cell synapses and climbing fiber-Purkinje cell synapses. The channel's high voltage sensitivity and rapid inactivation properties make it ideal for precise temporal control of synaptic signaling.
Dendritic Excitability: In Purkinje cell dendrites, P/Q channels mediate calcium influx in response to excitatory synaptic input, triggering long-term depression (LTD) — a key mechanism for cerebellar learning.
Pacemaker Activity: In cerebellar interneurons and some neuronal populations, CaV2.1 channels contribute to rhythmic firing patterns essential for motor coordination.
The SCA6 mutation involves CAG trinucleotide repeat expansion in the CACNA1A gene, producing an expanded polyglutamine (polyQ) tract in the resulting protein[@watase2008]. Key aspects include:
Normal Repeat Length: 4-16 CAG repeats
Pathogenic Range: 20-33 repeats
Anticipation: Larger repeats correlate with earlier onset and more severe disease
Unlike many polyglutamine diseases, SCA6 appears to involve both channel dysfunction and toxic gain-of-function mechanisms:
Channel Dysfunction:
- Altered channel gating properties
- Reduced current density in Purkinje cells
- Impaired synaptic plasticity
- Abnormal calcium homeostasis[@du2013]
Toxic Gain-of-Function:
- Polyglutamine-containing protein aggregates
- Transcriptional dysregulation
- Mitochondrial dysfunction
- Oxidative stress[@torrente2011]
SCA6 is characterized by selective degeneration of Purkinje cells[@cvetkovic2004]:
Neuropathological Features:
- Severe Purkinje cell loss in the cerebellar cortex
- Atrophy of the cerebellar vermis
- Degeneration of inferior olive nuclei
- Relative sparing of other cerebellar neuron types
- Minimal involvement of extra-cerebellar regions
Molecular Pathogenesis:
- Impaired P/Q channel function leads to reduced calcium signaling
- Disrupted synaptic plasticity at parallel fiber-Purkinje cell synapses
- Progressive Purkinje cell degeneration
- Dysfunction of cerebellar output pathways[@kordas2016]
Calcium homeostasis is profoundly disrupted in SCA6[@satput2018][@migliore2021]:
ER Calcium Depletion: P/Q channel dysfunction disrupts calcium release from endoplasmic reticulum stores, impairing calcium-dependent signaling pathways.
Mitochondrial Calcium Overload: Secondary mitochondrial calcium dysregulation leads to metabolic dysfunction and apoptosis.
Calpain Activation: Dysregulated calcium activates calpain proteases, contributing to protein degradation and cell death.
Calcium dyshomeostasis affects multiple downstream pathways:
PKC and CaMKII: Altered calcium-dependent kinase activation affects synaptic plasticity mechanisms.
cAMP/PKA Signaling: P/Q channels modulate cAMP levels, affecting neuronal excitability.
ERK/MAPK Pathway: Calcium-dependent MAPK activation is disrupted, impacting cell survival.
NF-κB Signaling: Calcium dysregulation influences inflammatory responses in cerebellar cells.
Clinical Features[@yabe2003][@soong2005]:
- Progressive cerebellar ataxia (gait, limb, speech)
- Dysarthria (slurred speech)
- Nystagmus (involuntary eye movements)
- Vertigo and balance problems
- Late-onset (typically 40-60 years)
Disease Course:
- Slowly progressive over decades
- Moderate disability in later stages
- Life expectancy generally normal
- Variable intrafamilial severity
FHM1 is caused by different CACNA1A mutations (gain-of-function) than SCA6:
- Transient hemiparesis during migraine attacks
- Cerebellar ataxia in some families
- Seizures possible
- Aura symptoms typical
CACNA1A loss-of-function mutations cause EA2:
- Episodic ataxia episodes (hours to days)
- Between-episode ataxia (mild)
- Responds to acetazolamide treatment
P/Q-type calcium channel (CaV2.1) shows high expression in:
Cerebellum:
- Purkinje cells (highest expression)
- Cerebellar interneurons (basket cells, stellate cells)
- Deep cerebellar nuclei
Brainstem:
- Inferior olive nuclei
- Cochlear nuclei
- Vestibular nuclei
Cerebral Cortex:
- Layer 5 pyramidal neurons
- Hippocampal CA1 neurons
The channel is particularly enriched in neurons requiring P/Q-mediated calcium influx for:
- High-frequency synaptic transmission
- Precision timing in sensory processing
- Synaptic plasticity mechanisms
Mouse models expressing expanded CAG repeats in CACna1a demonstrate[@watase2008]:
- Progressive Purkinje cell degeneration
- Ataxic gait and motor coordination deficits
- Abnormal calcium handling
- Synaptic transmission deficits
- Purkinje cell-specific vulnerability
- Age-dependent disease progression
- Rescue with channel modulators
- Therapeutic target validation
| Approach |
Mechanism |
Status |
| Acetazolamide |
Carbonic anhydrase inhibitor |
EA2 approved, some SCA6 benefit |
| 4-Aminopyridine |
Potassium channel blocker |
Reduces ataxia symptoms |
| Amantadine |
NMDA antagonist |
Mixed results |
| Riluzole |
Multi-modal |
Clinical trials ongoing |
Gene Therapy Approaches[@zhang2019][@cuny2022]:
- RNA interference to reduce mutant allele expression
- CRISPR-based gene editing
- Delivery of wild-type CACNA1A
- Polyglutamine aggregation inhibitors
Calcium Homeostasis Modulators:
- L-type calcium channel blockers
- SERCA pump enhancers
- Mitochondrial protectants
- Calcium chelators
Neuroprotective Strategies:
- Antioxidant therapy
- Anti-apoptotic agents
- neurotrophic factors
- Exercise and rehabilitation
The CaV2.1 channel interacts with multiple regulatory proteins[@marqueze2015]:
Channel-Associated Proteins:
- α2δ-1 subunit (auxiliary subunit)
- β1-4 subunits (auxiliary subunits)
- Syntaxin 1A
- SNAP-25
- Synaptotagmin
Modulatory Proteins:
- RYR3 (ryanodine receptor)
- CaBP1 (calcium-binding protein)
- Homer proteins
- PSD-95 family
P/Q channels modulate:
- cAMP/PKA Pathway: Through Gi/o protein coupling
- MAPK/ERK Pathway: Calcium-dependent activation
- PI3K/Akt Pathway: Cell survival signaling
- NFAT Transcription: Calcium-dependent gene expression
- CACNB4 — Auxiliary subunit mutations cause SCA
- CACNA1E — Related R-type channel
- RYR1 — Related calcium release channel
- PCR-based CAG repeat sizing
- Fragment analysis
- Next-generation sequencing panels
- Whole exome sequencing
- Serum/CSF neurofilament light chain
- MRI cerebellar volumetry
- Quantitative motor assessments
- Eye movement recordings
- Patient-derived iPSC models
- CRISPR screening
- High-throughput drug screens
- Gene therapy vectors
- What determines selective Purkinje cell vulnerability?
- Can polyglutamine expansion be reversed?
- What is the optimal therapeutic window for intervention?
- Can biomarkers predict progression?
- Antisense oligonucleotides
- Small molecule channel modulators
- Gene replacement therapy
- Cell replacement approaches
- Zhuchenko O, et al, Autosomal dominant cerebellar ataxia associated with polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel (1997)
- Pietrobon R, CaV2.1 channel dysfunction in cerebellar ataxia (2010)
- Matsushita Y, et al, Spinocerebellar ataxia type 6: CAG repeat expansion in alpha 1A calcium channel gene (1999)
- Johansson J, et al, Spinocerebellar ataxia type 6 in Sweden (1988)
- Mariotti C, et al, Molecular pathogenesis of spinocerebellar ataxias (2005)
- Schorge S, et al, P/Q-type calcium channel mutations in neurological disease (2010)
- Du X, et al, Calcium channel dysfunction in cerebellar granule neurons from SCA6 mice (2013)
- Torrente M, et al, Identifying modifiers of CaV2.1 channel dysfunction in polyglutamine diseases (2011)
- Marqueze B, et al, P/Q-type calcium channel regulation by neuronal calcium sensor proteins (2015)
- Kordas G, et al, Purkinje cell dysfunction in SCA6: insights from mouse models (2016)
- Satput S, et al, Intracellular calcium homeostasis in SCA6 pathophysiology (2018)
- Chourasia N, et al, Cerebellar degeneration in polyglutamine diseases (2020)
- Migliore L, et al, Calcium dysregulation in SCA6 pathogenesis (2021)
- Watase K, et al, Spinocerebellar ataxia type 6 knockin mice with expanded CAG repeats (2008)
- Ishida S, et al, GABAergic neurotransmission in SCA6 Purkinje cells (2016)
- Zhang Y, et al, Neuroprotective strategies for SCA6 (2019)
- Soong BW, et al, Genetic epidemiology of spinocerebellar ataxia in Taiwan (2005)
- Cvetkovic-Dojcinovic V, et al, Neuropathology of SCA6: selective Purkinje cell loss (2004)
- Yabe I, et al, Spinocerebellar ataxia type 6: clinical features and molecular epidemiology (2003)
- Cuny E, et al, Therapeutic approaches for SCA6 (2022)